2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Sarcoma, Ewing
1
Sarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Lymphoma, Follicular
1
Genetic Predisposition to Disease
1
Interventions
Surveys and Questionnaires
543
Blood Specimen Collection
447
Surgical Procedures, Operative
165
Observation
152
Drug Therapy
143
Radiotherapy
142
Interviews as Topic
139
Gene Expression Profiling
129
Biopsy
117
Magnetic Resonance Spectroscopy
116
Immunohistochemistry
112
Data Collection
95
Polymerase Chain Reaction
87
Specimen Handling
81
Amplified Fragment Length Polymorphism Analysis
81
Bevacizumab
79
Microarray Analysis
76
Flow Cytometry
69
Neoadjuvant Therapy
68
Watchful Waiting
67
Magnetic Resonance Imaging
65
Immune Checkpoint Inhibitors
62
Nivolumab
60
Immunotherapy
57
Therapeutics
55
Reverse Transcriptase Polymerase Chain Reaction
52
pembrolizumab
50
Ultrasonography
47
Positron Emission Tomography Computed Tomography
47
Hematologic Tests
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Genome-Wide Association Study
×
Clear all
NCT01210209
2021-05-19
GENEWING
Institut Curie
Completed
350 enrolled
NCT03234140
2017-07-31
CONPIL
Hospices Civils de Lyon
Unknown
1,883 enrolled